Shawn C. Burgess, Ph.D.
Affiliations: | 1995-2000 | Chemistry | University of Texas at Dallas, Richardson, TX, United States |
2000- | Center for Human Nutrition and Department of Pharmacology | University of Texas Southwestern Medical Center at Dallas, Dallas, TX, United States |
Google:
"Shawn Burgess"Mean distance: 10.19 | S | N | B | C | P |
Parents
Sign in to add mentorA. Dean Sherry | grad student | 2000 | UT Dallas | |
(Practicum Three, August 2000. Novel applications of carbon-13 indirect detection NMR to metabolic tracer studies in small tissue samples. Practicum Two, December 1998. Proton and platinum-195 NMR spectroscopic characterization of the products formed in re) | ||||
Craig R Malloy | post-doc |
Children
Sign in to add traineeSanthosh Satapati | grad student | 2010 | UT Dallas |
Matthew Potthoff | post-doc | University of Texas Southwestern Medical Center at Dallas (DevTree) | |
Alexandre Caron | post-doc | 2019-2020 | UT Southwestern (Neurotree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Deja S, Fletcher JA, Kim CW, et al. (2024) Hepatic malonyl-CoA synthesis restrains gluconeogenesis by suppressing fat oxidation, pyruvate carboxylation, and amino acid availability. Cell Metabolism |
Yiew NKH, Deja S, Ferguson D, et al. (2023) Effects of hepatic mitochondrial pyruvate carrier deficiency on lipogenesis and gluconeogenesis in mice. Iscience. 26: 108196 |
Fu X, Fletcher JA, Deja S, et al. (2023) Persistent fasting lipogenesis links impaired ketogenesis with citrate synthesis in humans with non-alcoholic fatty liver. The Journal of Clinical Investigation |
Yiew NKH, Ferguson D, Cho K, et al. (2023) Effects of hepatic mitochondrial pyruvate carrier deficiency on de novo lipogenesis and glycerol-mediated gluconeogenesis in mice. Biorxiv : the Preprint Server For Biology |
Martino MR, Gutiérrez-Aguilar M, Yiew NKH, et al. (2022) Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids. Cell Reports. 39: 110733 |
Deja S, Duarte J, Fletcher JA, et al. (2020) 368-OR: Activation of Hepatic Gluconeogenesis Is Required to Suppress DNL and Stimulate Ketogenesis during Fasting Diabetes. 69 |
Deja S, Fletcher JA, Kucejova B, et al. (2020) 204-OR: Inhibition of Hepatic ACC on a High-Fat Diet Results in Hyperglycemia and Hepatomegaly Due to Excess Energy Generation Diabetes. 69 |
Inigo MMR, Deja S, Kucejova B, et al. (2020) 1809-P: Liver Pyruvate Carboxylase Knockout Mice Suggest Noncanonical Sources of Acetyl-CoA for Hepatic Lipid Synthesis Diabetes. 69 |
Kucejova B, Deja S, Duarte J, et al. (2020) 1721-P: In Vivo Effect of Perturbations in Hepatic Insulin Signaling on the Synthesis and Export of De Novo Synthesized Fatty Acids and Triglycerides Diabetes. 69 |
Deja S, Fu X, Fletcher JA, et al. (2019) Simultaneous tracers and a unified model of positional and mass isotopomers for quantification of metabolic flux in liver. Metabolic Engineering |